Access. Intelligence. Excellence

Advanced Search

Home > Products & Services > Benchmarking Reports > Medical Affairs

Building Best-in-Class Medical Affairs Capabilities In India – A Case Study For High-Growth Emerging Markets

Features:

9	Info Graphics
21	Data Graphics
150+	Metrics
14	Narratives

Pages: 61

Delivery Format: Shipped

Call 919-403-0251

ID: POP-249

License Options: price info

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.

Medical Affairs function at bio-pharmaceutical companies plays a vital role in bridging the gap between commercial and R&D operations. Evidently, across the global healthcare landscape, the Medical Affairs function is essential to meeting current challenges in clinical development, market education, and regulatory compliance.

In� India, the Medical Affairs function is still developing, following a similar path to maturity as that traveled by MA groups in Mature Markets. Medical Affairs groups in India need to establish a clear value proposition in order to evolve beyond their traditional roles.

Best Practices, LLC's recent case study illustrates how mature and Indian biopharmaceutical companies include Abbott, Alkem Laboratories, AstraZeneca, Biocon, MSD Pharma, Ranbaxy, Sanofi & Astellas Pharma are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top success factors for the function particularly for Indian organizations.

Benchmark Class
Study Snapshot
Key Findings
View TOC and List of Exhibits

Industries Profiled:
Pharmaceutical; Biotech; Health Care; Biopharmaceutical; Diagnostic; Laboratories; Chemical; Technology; Medical Device; Manufacturing; Financial Services; Consumer Products

Companies Profiled:
Pfizer; LifeCell; Biocon; Biogen Idec; Alkem; AstraZeneca; Ipsen; Esteve; Guerbet; Endo Pharmaceuticals; Allergan; BD; Methapharm; GlaxoSmithKline ; Gilead Sciences; Ethicon; Johnson & Johnson; Mylan; Forest Laboratories; MedImmune; Upsher-Smith; Grunenthal; Phillips; Sandoz; Baxter International; ONYX; Xanodyne Pharmaceuticals; ViroPharma; Ranbaxy; Bristol-Myers Squibb; Novartis; Medtronic; Astellas; GE Healthcare; Eisai; Roche; Teva Pharmaceutical Industries Ltd; MSD; Bayer; Boehringer Ingelheim; Shire; Novo Nordisk; Sanofi Pasteur; Genentech; Cubist Pharmaceuticals; UCB Pharma; Sunovion; Valeant

Study Snapshot

This study engaged executives from 50 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Within the Mature Markets Segment, 41 participants make up the Pharmaceutical Segment, while the Medical Device Segment consists of 12 participants. The India Segment consists of 8 companies working actively in the India market.

Key topics include:

Medical Affairs: Scope & Structure
Medical Affairs: Leadership & Oversight
Medical Affairs: Regulatory Landscape & Challenges
Medical Affairs: Spend Allocations & Investment Benchmarks
Medical Affairs: Staffing Benchmarks
Medical Affairs: Functional Responsibility & Service Benchmarks
Medical Affairs: Budget Trends & Success Factor Benchmarks
Participant Demographic Data

Sample Key Findings

Global Scope of Medical Affairs: All Mature Market participants have a group dedicated to Medical Affairs. Among companies in India, 89% have a fully dedicated Medical Affairs group based in India, illustrating how Medical Affairs has grown into a global function with emerging market MA groups now a normal practice.

Mature Market Medical Affairs Reporting into R&D, Becoming Own Entity; India Medical Affairs Reporting to Commercial: Four out of 10 mature market groups in the benchmark class report to R&D. As a function, Medical Affairs tends to more aligned with R&D, reflecting a common drive to differentiate itself from the commercial side of the organization. However, half of India segment participants report into Commercial/Marketing highlighting the fact that MA in India is still in formative stages.

Table of Contents

Executive Summary

Research Overview
Participating Companies
Key Recommendations
Maturity of Medical Affairs
Key Findings & Insights

Scope & Structure
Leadership & Oversight
Regulatory Landscape & Challenges
Spend Allocation
Staffing
Functional Responsibility
Budget Trends & Success Factors
Participant Demographics

Sample List of Charts & Exhibits

Medical Affairs group dedication

Departmental reporting relationships
Job level or Medical Affairs head
Geographic span of organization
Percentage of spending per Medical Affairs function
Directional trends in Medical Affairs funding levels
Directional trends in staffing levels
Reasons cited for budget/staff increases
Reasons cited for budget/staff decreases
Relative importance of seven different Medical Affairs functions
Reasons cited for increased importance
Reasons cited for decreased importance
Percentage of budget allocated for outsourcing
Percent of companies impacted by FDA Revitalization Act
Top three success factors for developing and maintaining effective Medical Affairs group
Top three challenges for developing and maintaining effective Medical Affairs group

Related Research

Best Practices In Aligning the Medical Affairs Function to Meet Its Role in a Changing Healthcare Environment

The medical affairs function plays a critical role in dealing with a wide range of stakeholders, including thought leaders, who influence market access... (ID POP-251)
Companies Profiled: Astellas, Bard Peripheral, Bayer Medical Care, Spectranetics, read more ...

Price: $7680.00 Free Excerpt Available

Building Best-in-Class Capabilities for Medical Affairs

Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency... (ID POP-228)
Companies Profiled: Abbott, Akron Molecules, Alkem Laboratories, Astellas, read more ...

Price: $6250.00 Free Excerpt Available

How Medical Affairs Creates Value & Relationships through Service to Critical External Groups

With unprecedented changes in the healthcare industry, the Medical Affairs function is now responsible for building relationships and demonstrating value across a wide range of stakeholders... (ID POP-293)
Companies Profiled: Abbott, Amgen, ApotheCom, Astellas, read more ...

Price: $6000.00 Free Excerpt Available

Best Practices in Improving Medical Affairs Booth Impact at Critical Medical Congresses

Pharmaceutical companies spend a lot of money and resources on the medical booth exhibits that showcase their pipeline and products at key medical conferences or congresses... (ID POP-292)
Companies Profiled: Allergan, amag, Amgen, AstraZeneca, read more ...

Price: $6000.00 Free Excerpt Available

Benchmarking the Roles and Responsibilities for U.S.-Based Field Medical Team Interactions with Managed Care Customers

Pharmaceutical companies continue to improve the effectiveness of their managed care interactions by employing specialized medical liaisons who can speak the "payer language... (ID POP-283)
Companies Profiled: Abbvie, Bayer, Biogen, Boehringer Ingelheim, read more ...

Price: $6000.00 Free Excerpt Available

Driving the Value of Digital Initiatives in Medical Affairs

The wave of digital disruption in the healthcare industry has transformed the way Medical Affairs can engage with key internal and external stakeholders... (ID POP-296)
Companies Profiled: Abbott, Alkermes, Allergan, ApotheCom, read more ...

Price: $5900.00 Free Excerpt Available

Medical Affairs' Role in Patient Engagement Activities

The medical affairs function continues its evolution from a support-only function into an independent role, one that is critical to the success of pharmaceutical companies... (ID POP-280)
Companies Profiled: Abbvie, Actelion, Alkermes, AstraZeneca, read more ...

Price: $5800.00 Free Excerpt Available

Best Practices in Developing Top-Tier Medical Affairs Capabilities within Medical Device Companies

The Medical Affairs function has evolved into one of the most vital functions for the medical device industry... (ID POP-260)
Companies Profiled: Axon Pharma, BARD, Baxter, Bayer, read more ...

Price: $5100.00 Free Excerpt Available

Medical Affairs Strategies to Deliver Value to Payer Groups

In recent times, pharmaceutical companies have turned to their Medical Affairs function to establish meaningful relationships with payer groups, including Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs), owing to their rising influence on market access... (ID POP-284)
Companies Profiled: Abbott, Abbvie, Actelion, Astellas, read more ...

Price: $5000.00 Free Excerpt Available

Best Practices in Communicating and Disseminating Medical Information to External Stakeholders

The Medical Information function within pharmaceutical, biotechnology and medical device companies is responsible for disseminating critical and diverse information to key external stakeholders such as HCPs, payers, formulary decision makers, clinical investigators, contracted HCP speakers, and government agencies... (ID POP-297)
Companies Profiled: Abbott, AbbVie, Amicus Therapeutics, Bayer, read more ...

Price: $4890.00 Free Excerpt Available

Best Practices in Developing Top-Tier Medical Affairs Capabilities, Creating Impact Measures and Improving Globalization

The Medical Affairs function plays a critical role in educating the marketplace about products and therapeutic disease states... (ID POP-255)
Companies Profiled: Astellas, UCB Pharma, Onyx Pharmaceuticals, Upsher-Smith, read more ...

Price: $4200.00 Free Excerpt Available

Best Practices in Establishing Medical Affairs Capabilities in Emerging Countries: Using Structure, Staffing, and Responsibilities to Create an Effective Medical Affairs Group in TMEA

With pharmaceutical companies facing diverse markets around the world, it is challenging to create and maintain an effective Medical Affairs group in less understood regions such as TMEA, which includes Turkey, Middle East, and South Africa... (ID POP-289)
Companies Profiled: Abbvie, AstraZeneca, Celgene, Gilead Sciences, read more ...

Price: $3700.00 Free Excerpt Available

ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE

Quick Links